Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.84% |
| 2 | Technology | 15.57% |
| 3 | Consumer Discretionary | 11.88% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Clearfield
CLFD
$395M
| $7.97M | 0.01% |
84,658
-62,100
| -42% | -$6.55M |
|
|
KC
1227
Kingsoft Cloud Holdings
KC
$3.49B
| $7.97M | 0.01% |
2,080,200
+289,800
| +16% | +$832K |
|
1228
Otter Tail
OTTR
$3.89B
| $7.94M | 0.01% |
135,304
-94,010
| -41% | -$5.63M |
|
|
HUYA
1229
Huya Inc
HUYA
$526M
| $7.94M | 0.01% |
2,009,924
-1,114,200
| -36% | -$2.82M |
|
|
TSE
1230
DELISTED
Trinseo
TSE
| $7.92M | 0.01% |
348,600
-82,800
| -19% | -$1.83M |
|
1231
Kornit Digital
KRNT
$775M
| $7.91M | 0.01% |
344,500
-232,200
| -40% | -$5.8M |
|
|
ARCH
1232
DELISTED
Arch Resources, Inc.
ARCH
| $7.91M | 0.01% |
55,400
-97,800
| -64% | -$14.3M |
|
1233
Alpha and Omega Semiconductor
AOSL
$915M
| $7.9M | 0.01% |
276,600
-43,100
| -13% | -$1.39M |
|
1234
Imperial Oil
IMO
$65.2B
| $7.9M | 0.01% |
162,009
+20,400
| +14% | +$1.05M |
|
|
SFIX
1235
Stitch Fix
SFIX
$472M
| $7.85M | 0.01% |
2,524,800
+775,300
| +44% | +$2.9M |
|
1236
Old Second Bancorp
OSBC
$1.32B
| $7.85M | 0.01% |
489,425
-21,800
| -4% | -$348K |
|
1237
BridgeBio Pharma
BBIO
$15.4B
| $7.85M | 0.01% |
1,029,946
-336,800
| -25% | -$3.22M |
|
1238
nCino
NCNO
$2.24B
| $7.83M | 0.01% |
296,100
+158,200
| +115% | +$4.45M |
|
|
UNVR
1239
DELISTED
Univar Solutions Inc.
UNVR
| $7.82M | 0.01% |
246,002
-585,900
| -70% | -$16.8M |
|
1240
Jefferies Financial Group
JEF
$12.8B
| $7.82M | 0.01% |
238,581
-123,010
| -34% | -$4.09M |
|
|
BAND
1241
Bandwidth Inc
BAND
$1.71B
| $7.82M | 0.01% |
340,600
-23,600
| -6% | -$429K |
|
1242
Peapack-Gladstone Financial
PGC
$829M
| $7.82M | 0.01% |
210,020
-13,800
| -6% | -$527K |
|
|
EGRX
1243
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $7.79M | 0.01% |
266,650
-7,629
| -3% | -$243K |
|
|
LOGC
1244
DELISTED
ContextLogic
LOGC
| $7.79M | 0.01% |
532,500
+137,312
| +35% | +$2.82M |
|
1245
Embotelladora Andina Series B
AKO.B
$4.88B
| $7.76M | 0.01% |
535,081
-30,334
| -5% | -$352K |
|
1246
Nutanix
NTNX
$18.1B
| $7.76M | 0.01% |
297,800
+111,000
| +59% | +$3.03M |
|
1247
Information Services Group
III
$250M
| $7.75M | 0.01% |
1,685,710
-113,900
| -6% | -$576K |
|
1248
SIGA Technologies
SIGA
$207M
| $7.72M | 0.01% |
1,048,326
-1,304,921
| -55% | -$11.4M |
|
1249
Varonis Systems
VRNS
$5.15B
| $7.66M | 0.01% |
319,900
+308,100
| +2,611% | +$7.04M |
|
1250
Hanover Insurance
THG
$7.79B
| $7.65M | 0.01% |
+56,600
| New | +$7.89M |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 524 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.